Table 1 Patients’ clinicopathological features
Our cases (n = 469) | |
|---|---|
Age | 68.8 ± 9.4 |
Sex (men/women) | 385/84 (4.6/1) |
Clinical stage of disease (0/I/II/III/IV) | 81/76/68/118/126 |
Treatment* (ESD or EMR/OPE/CT and or RT/BSC) | 90/257/150/42 |
Outcome (alive/dead/unknown) | 160/212/97 |
Observation period (months) | 29.8 |
Drinking (%) | 392 (83.6%) |
Smoking (%) | 376 (80.2%) |
DM/HT/DL | 80/211/86 |
Diagnosis opportunity (medical checkup/outpatient consultation due to symptoms) | 129/270 |
History of cancer of other organs (%) | 154 (32.8%) |
Lesion location (Ce/Ut/Mt/Lt/Ae) | 25/91/271/69/10 |
Macroscopic tumor type (0/1/2/3/4/5) | 207/18/124/89/8/23 |
Histopathological grading (well/moderate/poor/unknown) | 91/243/71/64 |
Cases of stenosis (%) | 75 (16.0%) |
5-year survival rate | |
Stage 0 | 0.98 (95% CI 0.86–0.99) |
Stage I | 0.92 (95% CI 0.77–0.98) |
Stage II | 0.69 (95% CI 0.49–0.83) |
Stage III | 0.35 (95% CI 0.24–0.47) |
Stage IV | 0.16 (95% CI 0.07–0.29) |